Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Complete genome sequences of Clostridioides difficile surveillance isolates representing the top 10 ribotypes from the Emerging Infections Program, United States, 2016.
Adamczyk M, Vlachos N, Breaker E, Orazi G, Paulick AL, Rowe LA, McAllister G, Machado M-J, Korhonen L, Guh AY, Rasheed JK, Karlsson M, McKay SL, Lutgring JD, Gargis AS; Emerging Infections Program Clostridioides difficile Pathogen Group. Adamczyk M, et al. Among authors: paulick al. Microbiol Resour Announc. 2024 Jul 18;13(7):e0112823. doi: 10.1128/mra.01128-23. Epub 2024 May 29. Microbiol Resour Announc. 2024. PMID: 38809010 Free PMC article.
Characterization of Clostridioides difficile Isolates Available through the CDC & FDA Antibiotic Resistance Isolate Bank.
Paulick A, Adamczyk M, Anderson K, Vlachos N, Machado MJ, McAllister G, Korhonen L, Guh AY, Halpin AL, Rasheed JK, Karlsson M, Lutgring JD, Gargis AS; Emerging Infections Program Clostridioides difficile Pathogen Group. Paulick A, et al. Microbiol Resour Announc. 2021 Jan 7;10(1):e01011-20. doi: 10.1128/MRA.01011-20. Microbiol Resour Announc. 2021. PMID: 33414286 Free PMC article.
Correction for Paulick et al., "Characterization of Clostridioides difficile Isolates Available through the CDC & FDA Antibiotic Resistance Isolate Bank".
Paulick A, Adamczyk M, Anderson K, Vlachos N, Machado MJ, McAllister G, Korhonen L, Guh AY, Halpin AL, Rasheed JK, Karlsson M, Lutgring JD, Gargis AS; Emerging Infections Program Clostridioides difficile Pathogen Group. Paulick A, et al. Microbiol Resour Announc. 2022 May 19;11(5):e0030222. doi: 10.1128/mra.00302-22. Epub 2022 Apr 27. Microbiol Resour Announc. 2022. PMID: 35475673 Free PMC article. No abstract available.
Reference Susceptibility Testing and Genomic Surveillance of Clostridioides difficile, United States, 2012-17.
Gargis AS, Karlsson M, Paulick AL, Anderson KF, Adamczyk M, Vlachos N, Kent AG, McAllister G, McKay SL, Halpin AL, Albrecht V, Campbell D, Korhonen LC, Elkins CA, Rasheed JK, Guh AY, McDonald LC, Lutgring JD; Emerging Infections Program C. difficile Infection Working Group. Gargis AS, et al. Among authors: paulick al. Clin Infect Dis. 2023 Mar 4;76(5):890-896. doi: 10.1093/cid/ciac817. Clin Infect Dis. 2023. PMID: 36208202 Free PMC article.
Comparison of the Risk of Recurrent Clostridioides Difficile Infections Among Patients in 2018 Versus 2013.
Guh AY, Yi SH, Baggs J, Winston L, Parker E, Johnston H, Basiliere E, Olson D, Fridkin SK, Mehta N, Wilson L, Perlmutter R, Holzbauer SM, D'Heilly P, Phipps EC, Flores KG, Dumyati GK, Hatwar T, Pierce R, Ocampo VLS, Wilson CD, Watkins JJ, Korhonen L, Paulick A, Adamczyk M, Gerding DN, Reddy SC. Guh AY, et al. Open Forum Infect Dis. 2022 Aug 17;9(9):ofac422. doi: 10.1093/ofid/ofac422. eCollection 2022 Sep. Open Forum Infect Dis. 2022. PMID: 36072699 Free PMC article.
Reply to Gonzales-Luna et al.
Gargis AS, Karlsson M, Kamile Rasheed J, Kent AG, McKay SL, Paulick AL, Anderson KF, Adamczyk M, Campbell D, Korhonen LC, McAllister G, Vlachos N, Halpin AL, Lutgring JD, Guh AY, Clifford McDonald L, Elkins CA. Gargis AS, et al. Among authors: paulick al. Clin Infect Dis. 2023 Jun 8;76(11):2039-2041. doi: 10.1093/cid/ciad133. Clin Infect Dis. 2023. PMID: 36883575 Free PMC article. No abstract available.
Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes.
Guh AY, Mu Y, Winston LG, Johnston H, Olson D, Farley MM, Wilson LE, Holzbauer SM, Phipps EC, Dumyati GK, Beldavs ZG, Kainer MA, Karlsson M, Gerding DN, McDonald LC; Emerging Infections Program Clostridioides difficile Infection Working Group. Guh AY, et al. N Engl J Med. 2020 Apr 2;382(14):1320-1330. doi: 10.1056/NEJMoa1910215. N Engl J Med. 2020. PMID: 32242357 Free PMC article.
Toxin Enzyme Immunoassays Detect Clostridioides difficile Infection With Greater Severity and Higher Recurrence Rates.
Guh AY, Hatfield KM, Winston LG, Martin B, Johnston H, Brousseau G, Farley MM, Wilson L, Perlmutter R, Phipps EC, Dumyati GK, Nelson D, Hatwar T, Kainer MA, Paulick AL, Karlsson M, Gerding DN, McDonald LC. Guh AY, et al. Among authors: paulick al. Clin Infect Dis. 2019 Oct 30;69(10):1667-1674. doi: 10.1093/cid/ciz009. Clin Infect Dis. 2019. PMID: 30615074 Free PMC article.
Infectious Period of Severe Acute Respiratory Syndrome Coronavirus 2 in 17 Nursing Home Residents-Arkansas, June-August 2020.
Surie D, Huang JY, Brown AC, Gable P, Biedron C, Gilbert SE, Garner K, Bollinger S, Gulley T, Haney T, Lyons AK, Beshearse E, Gregory CJ, Sabour S, Clemmons NS, James AE, Tamin A, Reese N, Perry-Dow KA, Brown R, Harcourt JL, Campbell D, Houston H, Chakravorty R, Paulick A, Whitaker B, Murdoch J, Spicer L, Stumpf MM, Mills L, Coughlin MM, Higdem P, Rasheed MAU, Lonsway D, Bhatnagar A, Kothari A, Anderson K, Thornburg NJ, Breaker E, Adamczyk M, McAllister GA, Halpin AL, Seely KA, Patil N, McDonald LC, Kutty PK. Surie D, et al. Among authors: paulick a. Open Forum Infect Dis. 2021 Jan 30;8(3):ofab048. doi: 10.1093/ofid/ofab048. eCollection 2021 Mar. Open Forum Infect Dis. 2021. PMID: 33723510 Free PMC article.
17 results